Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy

被引：35

作者：

Landau, A ^{[1
]}

Batisse, D ^{[1
]}

Piketty, C ^{[1
]}

Jian, R ^{[1
]}

Kazatchkine, MD ^{[1
]}

机构：

[1] Univ Paris 06, Hop Europeen Georges Pompidou, Serv Hepatol & Gastro Enterol, Paris, France

来源：

AIDS | 2000年 / 14卷 / 12期

关键词：

D O I：

10.1097/00002030-200008180-00025

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1857 / 1858

页数：2

共 8 条

[1] Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].

Benhamou, Y ;

Bochet, M ;

Di Martino, V ;

Charlotte, F ;

Azria, F ;

Coutellier, A ;

Vidaud, M ;

Bricaire, F ;

Opolon, P ;

Katlama, C ;

Poynard, T .

HEPATOLOGY, 1999, 30 (04) :1054-1058

[2] Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C [J].

Darby, SC ;

Ewart, DW ;

Giangrande, PLF ;

Spooner, RJD ;

Rizza, CR ;

Dusheiko, GM ;

Lee, CA ;

Ludlam, CA ;

Preston, FE .

LANCET, 1997, 350 (9089) :1425-1431

[3] CHANGES IN THE BONE-MARROW OF CANCER-PATIENTS TREATED WITH RECOMBINANT INTERFERON ALPHA-2 [J].

ERNSTOFF, MS ;

KIRKWOOD, JM .

AMERICAN JOURNAL OF MEDICINE, 1984, 76 (04) :593-596

[4] Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro [J].

Hoggard, PG ;

Kewn, S ;

Barry, MG ;

Khoo, SH ;

Back, DJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1231-1236

[5] Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients [J].

Landau, A ;

Batisse, D ;

Van Huyen, JPD ;

Piketty, C ;

Bloch, F ;

Pialoux, G ;

Belec, L ;

Petite, JP ;

Weiss, L ;

Kazatchkine, M .

AIDS, 2000, 14 (07) :839-844

[6] Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus [J].

Poynard, T ;

Marcellin, P ;

Lee, SS ;

Niederau, C ;

Minuk, GS ;

Ideo, G ;

Bain, V ;

Heathcote, J ;

Zeuzem, S ;

Trepo, C ;

Albrecht, J .

LANCET, 1998, 352 (9138) :1426-1432

[7] Management of chronic hepatitis C in HIV-infected patients [J].

Soriano, V ;

Rodríguez-Rosado, R ;

García-Samaniego, J .

AIDS, 1999, 13 (05) :539-546

[8] Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections [J].

Zylberberg, H ;

Pol, S .

CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) :1117-1125

← 1 →